MOLECULE | BRAND | STRENGTH | COMPOSITION | PACK SIZE | THERAPY |
Torasemide, Spironolactone Torsid Plus 10 mg, 50 mg Each uncoated tablet contains: Torasemide IP 10 mg, Spironolactone IP 50 mg 10's Diuretic Torasemide, Spironolactone Torsid Plus 20 mg, 50 mg Each uncoated tablet contains: Torasemide IP 20 mg, Spironolactone IP 50 mg 10's Diuretic Tranexamic Acid Tranlok 500mg Each tablet contains: Tranexamic Acid IP 500mg 10's Haemostatic Tranexamic Acid Tranlok Injection 500mg Each 5ml ampoule contains: Tranexamic Acid IP 500mg 5ml Ampoule Haemostatic Tranexamic Acid, Ethamsylate Tranlok-E 500mg, 250mg Each film coated tablet contains: Tranexamic Acid IP 500mg, Etamsylate BP 250mg 10's Haemostatic Tranexamic Acid, Mefenamic Acid Tranlok-M 500mg, 250mg Each film coated tablet contains: Tranexamic Acid IP 500mg, Mefenamic Acid IP 250mg 10's Haemostatic Glimepiride, Metformin, Pioglitazone Triglimiprex 1 1mg, 500mg SR, 15mg Each uncoated bi-layered tablet contains: Glimepiride 1mg, Pioglitazone Hydrochloride IP equivalent to Pioglitazone 15mg, Metformin Hydrochloride IP (in sustained release form) 500mg 10's Anti-Diabetic Oral Glimepiride, Metformin, Pioglitazone Triglimiprex 2 2mg, 500mg SR, 15mg Each uncoated bi-layered tablet contains: Glimepiride 2mg, Pioglitazone Hydrochloride IP equivalent to Pioglitazone 15mg, Metformin Hydrochloride IP (in sustained release form) 500mg 10's Anti-Diabetic Oral Voglibose, Metformin, Glimepiride TriMegavog 1 0.2mg, 500mg ER, 1mg Each uncoated bi-layered tablet contains: Metformin Hydrochloride IP 500mg (in sustained release form), Glimepiride IP 1mg, Voglibose JP 0.2mg 10's Anti-Diabetic Oral Voglibose, Metformin, Glimepiride TriMegavog 2 0.2mg, 500mg SR, 2mg Each uncoated bi-layered tablet contains: Metformin Hydrochloride IP 500mg (in sustained release form), Glimepiride IP 2mg, Voglibose JP 0.2mg 10's Anti-Diabetic Oral